Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takumi Kageyama

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Urology|March 19, 2016
Clinical Effect of Switching from a Luteinizing Hormone-Releasing Hormone Agonist to an Antagonist in Patients with Castration-Resistant Prostate Cancer and Serum Testosterone Level ≥ 20 ng/dlNorihito Soga, Takumi Kageyama, Yuji Ogura, et al.
Current Urology|October 4, 2019
The GP Score, a Simplified Formula (Bioptic Gleason Score Times Prostate Specific Antigen) as a Predictor for Biochemical Failure after Prostatectomy in Prostate CancerNorihito Soga, Yuji Ogura, Toshiaki Wakita, et al.
Asia-Pacific Journal of Clinical Oncology|January 27, 2017
Very high-risk prostate cancer: stratification by outcomes of radiotherapy and long-term androgen deprivation therapyNatsuo Tomita, Norihito Soga, Yuji Ogura, et al.
Cancers|May 13, 2023
Roles of the PARP Inhibitor in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor MicroenvironmentTakahiro Inoue, Sho Sekito, Takumi Kageyama, et al.
Urologia Internationalis|October 3, 2015
Review of Bioptic Gleason Scores by Central Pathologist Modifies the Risk Classification in Prostate CancerNorihito Soga, Yasushi Yatabe, Takumi Kageyama, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 21, 2016
[A Case of Intrascrotal Liposarcoma]Takumi Kageyama, Yuji Ogura, Ikuo Hyodo, et al.
IJU Case Reports|November 7, 2022
Dramatic response to pembrolizumab after pseudoprogression in a patient with advanced metastatic castration-resistant prostate cancerTakumi Kageyama, Norihito Soga, Sho Sekito, et al.
The Prostate|December 8, 2022
Prostate fibroblasts enhance androgen receptor splice variant 7 expression in prostate cancer cellsTakeshi Sasaki, Yumi Yoshikawa, Takumi Kageyama, et al.
Cancer Medicine|June 26, 2025
Narrative Review of Patient Cancer Tissue-Derived Zebrafish Xenograft Models for Evaluating Drug Sensitivity as an Avatar Model for Clinical ApplicationYusuke Sugino, Xin Bao, Takumi Kageyama, et al.
International Journal of Molecular Sciences|July 13, 2024
Purine-Rich Element Binding Protein Alpha, a Nuclear Matrix Protein, Has a Role in Prostate Cancer ProgressionTakahiro Inoue, Xin Bao, Takumi Kageyama, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Urology|March 19, 2016
Clinical Effect of Switching from a Luteinizing Hormone-Releasing Hormone Agonist to an Antagonist in Patients with Castration-Resistant Prostate Cancer and Serum Testosterone Level ≥ 20 ng/dlNorihito Soga, Takumi Kageyama, Yuji Ogura, et al.
Current Urology|October 4, 2019
The GP Score, a Simplified Formula (Bioptic Gleason Score Times Prostate Specific Antigen) as a Predictor for Biochemical Failure after Prostatectomy in Prostate CancerNorihito Soga, Yuji Ogura, Toshiaki Wakita, et al.
Asia-Pacific Journal of Clinical Oncology|January 27, 2017
Very high-risk prostate cancer: stratification by outcomes of radiotherapy and long-term androgen deprivation therapyNatsuo Tomita, Norihito Soga, Yuji Ogura, et al.
Cancers|May 13, 2023
Roles of the PARP Inhibitor in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Mutated Metastatic Prostate Cancer: Direct Functions and Modification of the Tumor MicroenvironmentTakahiro Inoue, Sho Sekito, Takumi Kageyama, et al.
Urologia Internationalis|October 3, 2015
Review of Bioptic Gleason Scores by Central Pathologist Modifies the Risk Classification in Prostate CancerNorihito Soga, Yasushi Yatabe, Takumi Kageyama, et al.
Hinyokika Kiyo. Acta Urologica Japonica|October 21, 2016
[A Case of Intrascrotal Liposarcoma]Takumi Kageyama, Yuji Ogura, Ikuo Hyodo, et al.
IJU Case Reports|November 7, 2022
Dramatic response to pembrolizumab after pseudoprogression in a patient with advanced metastatic castration-resistant prostate cancerTakumi Kageyama, Norihito Soga, Sho Sekito, et al.
The Prostate|December 8, 2022
Prostate fibroblasts enhance androgen receptor splice variant 7 expression in prostate cancer cellsTakeshi Sasaki, Yumi Yoshikawa, Takumi Kageyama, et al.
Cancer Medicine|June 26, 2025
Narrative Review of Patient Cancer Tissue-Derived Zebrafish Xenograft Models for Evaluating Drug Sensitivity as an Avatar Model for Clinical ApplicationYusuke Sugino, Xin Bao, Takumi Kageyama, et al.
International Journal of Molecular Sciences|July 13, 2024
Purine-Rich Element Binding Protein Alpha, a Nuclear Matrix Protein, Has a Role in Prostate Cancer ProgressionTakahiro Inoue, Xin Bao, Takumi Kageyama, et al.
Pageof 2